Risk-group-specific dose finding based on an average toxicity score.
about
Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials.Towards using a full spectrum of early clinical trial data: a retrospective analysis to compare potential longitudinal categorical models for molecular targeted therapies in oncology.Continual reassessment method with multiple toxicity constraints.Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials.Bayesian dose-finding designs for combination of molecularly targeted agents assuming partial stochastic orderingInteractive Software "Isotonic Design using Normalized Equivalent Toxicity Score (ID-NETS©TM)" for Cancer Phase I Clinical Trials.Sequential designs for individualized dosing in phase I cancer clinical trials.Dose finding with continuous outcome in phase I oncology trials.Escalation with Overdose Control Using Ordinal Toxicity Grades for Cancer Phase I Clinical Trials
P2860
Q30757656-B18E2563-EA17-437E-ADE5-A237E0CCCE5BQ30968729-0328D116-C90A-4719-B6D8-055EF00BD13FQ33392065-729EC232-9626-4B25-98C9-858B800669E7Q33714319-6A3C45FC-D80F-42C8-94D6-522BE99D429BQ35175343-EE827E69-1AC6-4B35-AAA6-38A5E6DB05BEQ36924666-2DD11B6E-FBB8-47EB-9C87-3E918B1E86DCQ38824605-3D98BCFE-17FD-434D-9E24-48B60E4F6646Q51010190-F8161EFE-18FE-4385-9DAA-80E3D6237D30Q58910958-FBA80C33-C36E-45BD-8F30-9DA8A4B83974
P2860
Risk-group-specific dose finding based on an average toxicity score.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Risk-group-specific dose finding based on an average toxicity score.
@ast
Risk-group-specific dose finding based on an average toxicity score.
@en
type
label
Risk-group-specific dose finding based on an average toxicity score.
@ast
Risk-group-specific dose finding based on an average toxicity score.
@en
prefLabel
Risk-group-specific dose finding based on an average toxicity score.
@ast
Risk-group-specific dose finding based on an average toxicity score.
@en
P2860
P1433
P1476
Risk-group-specific dose finding based on an average toxicity score
@en
P2093
B Nebiyou Bekele
P2860
P304
P356
10.1111/J.1541-0420.2009.01297.X
P407
P50
P577
2009-07-23T00:00:00Z